BUZZ — GenScript Biotech extends gain to hit near 5 — year peak on Eli Lilly deal

* Shares of GenScript Biotech Corp jump 8.2% to HK$40.28, their highest level since December 2021 * Stock extends a rally from the previous session after announcement of collaboration with Eli Lilly and Company * Stock third-biggest pct gainer in the Hang Seng Biotech Index, which climbs 1.8% * GenScript shares closed 14.3% higher on Thursday in their best day since August 7, after co announced collaboration with Lilly TuneLab, the AI/machine learning-based drug discovery collaboration platform of Eli Lilly * GenScript will provide wet lab services to TuneLab member companies to generate experimental data and translate AI generated predictions into biological evidence * YTD, stock up 216.3%, Hang Seng Biotech Index up 11.2% (Reporting by Donny Kwok) ((donny.kwok@thomsonreuters.com)